Code Waechter’s Pfizer PFE Stock Holding History

Code Waechter’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$673K	Buy	27,966 +188	+0.7%	+$4.92K	0.35%	55
2026 Q1	$780K	Buy	27,778 +162	+0.6%	+$4.31K	0.46%	48
2025 Q4	$688K	Buy	27,616 +5,105	+23%	+$129K	0.44%	54
2025 Q3	$552K	Buy	22,511 +1,911	+9%	+$47.2K	0.36%	59
2025 Q2	$499K	Buy	20,600 +7,374	+56%	+$172K	0.36%	63
2025 Q1	$335K	Buy	+13,226	New	+$346K	0.28%	84

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Code Waechter's PFE Position: Q2 2026 in Review

Code Waechter increased its Pfizer (PFE) stake by 0.68% in Q2 2026, buying an estimated $4.92K and bringing the position to 27,966 shares worth $673K. The position accounts for 0.35% of the portfolio, ranked #55.

Code Waechter first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $780K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Code Waechter held 27,966 shares of Pfizer worth $673K as of Q2 2026.
Code Waechter bought 188 Pfizer shares in Q2 2026, an estimated $4.92K.
Pfizer made up 0.35% of Code Waechter's portfolio in Q2 2026, its #55 holding.
Code Waechter first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
Code Waechter's Pfizer position peaked at $780K in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Code Waechter's 13F filing for Q2 2026, filed 31 Jul 2026.